IN-VITRO ACTIVITY OF THE NEW QUINOLONE BAY-Y-3118 AGAINST ANAEROBIC-BACTERIA

Authors
NORD CE LINDMARK A PERSSON I
Citation
Ce. Nord et al., IN-VITRO ACTIVITY OF THE NEW QUINOLONE BAY-Y-3118 AGAINST ANAEROBIC-BACTERIA, European journal of clinical microbiology & infectious diseases, 12(8), 1993, pp. 640-642
Citations number
3
Categorie Soggetti
Immunology,Microbiology
Journal title
European journal of clinical microbiology & infectious diseases → ACNP
ISSN journal
09349723
Volume
12
Issue
8
Year of publication
1993
Pages
640 - 642
Database
ISI
SICI code
0934-9723(1993)12:8<640:IAOTNQ>2.0.ZU;2-D
Abstract
The in vitro activity of BAY y 3118 against anaerobic cocci, Propionib acterium acnes, Clostridium perfringens, Clostridium difficile, Bacter oides fragilis, other Bacteroides spp. and fusobacteria was determined by an agar dilution method. This activity was compared with that of c iprofloxacin, ofloxacin, piperacillin, cefoxitin, imipenem, clindamyci n and metronidazole. BAY y 3118, imipenem, clindamycin and metronidazo le were the most active agents tested. The in vitro activity of BAY y 3118 against anaerobic bacteria was superior to that of ciprofloxacin and ofloxacin.